
Grant Thornton multinational platform to expand to include Switzerland, Liechtenstein and the Channel Islands
Earlier this year, Grant Thornton Advisors announced transactions to join the platform with UAE, Luxembourg, the Cayman Islands and the Netherlands. Through this rapidly growing multinational platform, clients across three continents will have access to seamless and enhanced cross-border services, which are underpinned by investments in technology, people and quality.
Adding footprints in Switzerland, Liechtenstein and the Channel Islands strengthens the platform's unified advisory and tax solutions, as well as its independent audit and assurance practices. It also creates a powerful network of professionals in European financial hubs — from Zurich and Geneva to Jersey and Guernsey, in addition to Bermuda, the Cayman Islands and UAE.
With the latest agreements, the Grant Thornton multinational platform will include approximately 13,500 professionals across nearly 60 offices stretching from the Americas across Europe to the Middle East. It is backed by an investor group led by New Mountain Capital — a growth-oriented investment firm with approximately $55 billion in assets under management.
The expanded platform will continue to be part of the Grant Thornton International Limited network, which comprises member firms in more than 150 markets worldwide.
'We are very pleased to have our colleagues in the Channel Islands, Switzerland and Liechtenstein join our differentiated and expanding platform,' said Jim Peko, CEO of Grant Thornton Advisors. 'We're building the world's most talented team — delivering seamless offerings through an expanded footprint. The result: an unparalleled client experience and unmatched quality.'
'Today's announcement represents further strong additions to our platform, with a shared focus on client centricity, quality and industry-service alignment,' added Steve Tennant, managing partner of Grant Thornton in Ireland. 'We look forward to welcoming new colleagues across Europe as we expand in several of the world's leading finance centers.'
Adam Budworth, managing partner of Grant Thornton Channel Islands, said: 'This is an exciting opportunity to support our growth in the Channel Islands with access to new service offerings, technologies and investment capital. Joining the platform will only enhance the reputation of the Channel Islands on a bigger stage, while at the same time creating unique opportunities for our people.'
'I am delighted about this positive development and am convinced that it is the right step for our firm in the current turbulent market environment,' said Erich Bucher, CEO of Grant Thornton Switzerland/Liechtenstein. 'It opens up completely new perspectives for us and will enable us to push ahead with our growth strategy much more quickly.'
'The Grant Thornton platform is supercharging itself with the quality, talent and advanced technologies that clients need and want,' said Andre Moura and Nikhil Devulapalli, managing directors at New Mountain Capital. 'The addition of these two firms — both well-respected in their markets and renowned for their finance expertise — will continue to elevate Grant Thornton's world-class and wide-reaching financial services offering.'
Both transactions are expected to close later this year, subject to regulatory approvals and other standard closing conditions.
About Grant Thornton
Grant Thornton delivers professional services in the US through two specialized entities: Grant Thornton LLP, a licensed, certified public accounting (CPA) firm that provides audit and assurance services ― and Grant Thornton Advisors LLC (not a licensed CPA firm), which exclusively provides non-attest offerings, including tax and advisory services.
Grant Thornton Ireland is a leading multinational professional services firm with approximately 2,800 people in offices across the island of Ireland, Bermuda, Isle of Man and Gibraltar. Their tax, audit and advisory teams work with organizations across sectors including technology, insurance, asset management, banking, life sciences, and aviation, as well as the public sector.
In January 2025, Grant Thornton Advisors LLC formed a multinational, multidisciplinary platform with Grant Thornton Ireland. The platform offers a premier advisory and tax practice, as well as independent audit practices.
With almost 60 offices across three continents — including the U.S., Ireland, the UAE and other territories — the platform delivers a singular client experience that includes enhanced solutions and capabilities, backed by powerful technologies and a roster of approximately 13,500 quality-driven professionals enjoying exceptional career-growth opportunities and a distinctive cross-border culture.
Grant Thornton LLP, Grant Thornton Advisors LLC and their respective subsidiaries operate as an alternative practice structure (APS). The APS conforms with applicable laws, regulations and professional standards, including those from the American Institute of Certified Public Accountants.
'Grant Thornton' refers to the brand under which the member firms in the Grant Thornton International Ltd (GTIL) network provide services to their clients and/or refers to one or more member firms. Grant Thornton LLP and Grant Thornton Advisors LLC serve as the U.S. member firms of the GTIL network. GTIL and its member firms are not a worldwide partnership and all member firms are separate legal entities. Member firms deliver all services; GTIL does not provide services to clients.
About Grant Thornton Limited, Channel Islands
Grant Thornton Limited is a leading Channel Island practice offering a range of audit, accounting, tax, recovery and organisation, and advisory services to local and businesses worldwide.
We have been operating in Guernsey and Jersey for more than 40 years and have over 300 professionals working within the firm. Grant Thornton Limited is a member firm within Grant Thornton International, one of the world's leading international organisations of accounting and consulting firms.
As a GTIL member firm, we have access to member and correspondent firms in more than 150 countries, offering clients specialist local knowledge supported by international expertise and methodologies.
About Grant Thornton Switzerland/Liechtenstein
Grant Thornton Switzerland/Liechtenstein is a renowned audit and advisory firm with a well-established tax department and extensive experience in outsourcing. The firm is run by 24 partners and employs around 220 specialists in Switzerland and Liechtenstein at its branches in Schaan, Zurich, Geneva and Buchs. Grant Thornton Switzerland/Liechtenstein has strong local roots and, as a member of Grant Thornton's international network, is linked at a global level. The scale of its operations as well as its concessions and licences permit Grant Thornton to meet the demands of discerning clients in both a national and international context.
About New Mountain Capital
New Mountain Capital is a New York-based investment firm that emphasizes business building and growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, credit and net lease investment strategies with approximately $55 billion in assets under management. New Mountain Capital seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit www.newmountaincapital.com.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Wire
18 minutes ago
- Business Wire
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit in the Unified Patent Court (UPC) of the European Union against Pfizer Inc. and certain of its subsidiaries (action number 35071/2025), seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid™ (nirmatrelvir tablets; ritonavir tablets). This enforcement action targets Pfizer's activities in the 18 countries of the European Union that are presently participating in the UPC. The European Patent Office's recent grant of the '265 Patent to Enanta was published in the European Patent Bulletin today. The '265 Patent is based on Enanta's July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists. The '265 Patent is the European counterpart of U.S. Patent No. 11,358,953 (the '953 Patent) involved in ongoing U.S. litigation between Enanta and Pfizer Inc. Under UPC procedures, a hearing on the infringement action is expected to occur within the UPC's published 12-month target, with the decision rendered within weeks thereafter. If the UPC determines there has been infringement, subsequent proceedings would be required to determine damages. All timelines remain subject to potential rights of appeal and other customary proceedings in European patent litigation. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET ® (U.S.) and MAVIRET ® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including statements with respect to Enanta's filing in the UPC of a suit against Pfizer Inc. and certain of its subsidiaries seeking a determination of liability for use and infringement of Enanta's patent and Enanta's expectations with respect to any further action with respect to such proceedings. Statements that are not historical facts are based on management's current expectations, estimates, forecasts and projections about Enanta's business and the industry in which it operates and management's beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including those covering one or more of its product candidates, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta's senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta's reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in 'Risk Factors' in Enanta's Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law.


CNBC
19 minutes ago
- CNBC
Why is the UK struggling with inflation, compared to the euro zone?
Florian IeIpo, head of macro at Lombard Odier Investment Managers, discuss sticky inflation in the U.K. and why the situation is different on the European continent.
Yahoo
an hour ago
- Yahoo
Grant Thornton Advisors to acquire consulting firm Stax
Grant Thornton Advisors has revealed plans to acquire Stax, a global strategy consulting company specialising in commercial due diligence, value creation, and exit planning services. Financial details of the deal have not been divulged by either of the companies. Based in Boston, Massachusetts, Stax operates in significant financial markets and provides support for both buy-side and sell-side diligence related to mergers and acquisitions. Stax's services are tailored for private equity firms, PE-backed companies, hedge funds, and investment banks across a range of industries including software/technology, industrials, business services, healthcare, consumer, and the events ecosystem. The firm employs a data-driven methodology that leverages advanced artificial intelligence to generate actionable insights for its clients. Stax CEO Jayson Traxler said: 'We are proud to have built a 30-year reputation for excellent client service, unique tech-enabled solutions and impressive growth. 'As part of Grant Thornton Advisors, those characteristics will endure — but with far greater scale, speed and amplification of our impact. 'We will be empowered to build on our unique strengths and insights, for the benefit of the leading PE firms, portfolio companies and investment banks.' This acquisition aims to strengthen Grant Thornton Advisors' transaction advisory capabilities, expanding its expertise in mergers and acquisitions. The firm currently has more than 600 relationships with private equity firms, including a significant portion of the top global players, and more than 1,600 clients backed by sponsors. The transaction is anticipated to close in 2025, subject to customary conditions, and will result in approximately 300 employees from Stax joining Grant Thornton Advisors. The combined entities will serve a large segment of the US Private Equity International 300. Grant Thornton Advisors CEO Jim Peko said: 'With this bold move, we're taking our platform to new heights — combining Stax's top-tier talent with our own industry-leading professionals, while broadening our offerings and further elevating our tech capabilities. 'Stax has a decades-long legacy delivering transformative value to clients — similar to our own 100-year history. Together, we will generate bold results for a PE client base stretching from the Americas across Europe to the Middle East.' This acquisition aligns with the multinational platform that Grant Thornton Advisors initiated in January 2025, which has already included partnerships with various accounting and consulting firms across multiple jurisdictions. In July 2025, Grant Thornton Advisors also announced its acquisition of Auxis, a firm known for its outsourcing and business-modernisation services. "Grant Thornton Advisors to acquire consulting firm Stax" was originally created and published by International Accounting Bulletin, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data